Serdar Karakas
Overview
Explore the profile of Serdar Karakas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Demiroz D, Colak Y, Ozdes O, Ucar M, Erdogan M, Toprak H, et al.
Indian J Crit Care Med
. 2024 Mar;
28(1):75-79.
PMID: 38510757
Background: Acute kidney injury (AKI) significantly contributes to the mortality and morbidity rates among pediatric liver transplant (LT) recipients. Objective: Our study aimed to assess the potential factors contributing to...
2.
Karakas S, Yilmaz S, Ince V, Akbulut S, Dalda Y, Akatli A, et al.
Hepatol Forum
. 2023 May;
4(2):47-52.
PMID: 37250925
Background And Aim: Liver resection (LR) and liver transplantation (LT) are curative treatments for hepatocellular carcinoma (HCC). The main purpose of this study was to compare the survival of LR...
3.
Akbulut S, Uremis M, Sarici K, Uremis N, Hargura A, Karakas S, et al.
Transpl Immunol
. 2022 Aug;
75:101697.
PMID: 35985614
Objective: This study aimed to compare oxidant and antioxidant substance accumulation in the liver tissues of patients with chronic liver disease (recipients) who underwent liver transplantation (LT) with living liver...
4.
Ince V, Carr B, Bag H, Ersan V, Usta S, Koc C, et al.
World J Gastrointest Surg
. 2021 Jan;
12(12):520-533.
PMID: 33437403
Background: There is increasing interest in transplanting patients with hepatocellular carcinoma (HCC) with tumors greater than 5 cm (Milan criteria). Aim: To investigate possible prognostically-useful factors for liver transplantation in...
5.
Dogan G, Dogan S, Okut G, Karakas S, Kutluturk K, Ulubaba H, et al.
Transplant Proc
. 2020 Sep;
53(1):104-110.
PMID: 32919802
Objectives: Splenomegaly and hypersplenism caused by liver failure increase the mortality and morbidity of patients even after liver transplantation if they do not regress. We evaluated the relation of splenic...
6.
Baskiran A, Akbulut S, Sahin T, Koc C, Karakas S, Ince V, et al.
Hepatol Int
. 2020 Sep;
14(5):869-880.
PMID: 32895876
Purpose: To evaluate the effect of hepatitis D virus (HDV) on hepatitis B virus-hepatocellular carcinoma (HBV-HCC) co-recurrence in patients undergoing living donor liver transplantation (LDLT) for HBV alone or HBV-HDV...
7.
Dirican A, Karakas S
J Gastrointest Cancer
. 2020 Aug;
51(4):1148-1151.
PMID: 32839945
Introduction: Liver transplantation remains the main curative treatment method for hepatocellular carcinoma. There are several criteria for hepatocellular carcinoma to be eligible for liver transplantation, and it depends on main...
8.
Ince V, Akbulut S, Otan E, Ersan V, Karakas S, Sahin T, et al.
J Gastrointest Cancer
. 2020 Jul;
51(3):1006.
PMID: 32643114
The original version of this article unfortunately contained a mistake in the author group section.
9.
Yilmaz S, Akbulut S, Koc C, Usta S, Baskiran A, Karakas S, et al.
Curr Opin Organ Transplant
. 2020 Jul;
25(4):442-444.
PMID: 32618721
No abstract available.
10.
Ince V, Akbulut S, Otan E, Ersan V, Karakas S, Sahin T, et al.
J Gastrointest Cancer
. 2020 Jun;
51(3):998-1005.
PMID: 32519232
Survival was examined from a Turkish liver transplant center of patients with HCC, to identify prognostic factors. Data from 215 patients who underwent predominantly live donor liver transplant for HCC...